Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
KdT Ventures is an early-stage venture capital firm founded in 2017 and headquartered in the United States. The firm specializes in investing in frontier science, particularly in the fields of chemistry and biology, with a mission to address significant global challenges through innovative technology. Since its inception, KdT Ventures has focused on identifying and supporting companies that are at the forefront of scientific advancements, particularly those that are commercializing breakthroughs at the molecular level. The firm has successfully raised multiple funds, although specific fund sizes and assets under management (AUM) are not publicly disclosed. KdT Ventures is known for its rigorous investment thesis, which emphasizes the integration of next-generation sequencing, artificial intelligence, and hyper-scale computing to model and alter biological systems. This strategic approach positions the firm as a leader in the venture capital landscape, particularly within the biotech and healthcare sectors.
KdT Ventures invests primarily in early-stage companies that are commercializing scientific advancements at the molecular level. The firm has a strong focus on sectors such as frontier science, biotechnology, healthcare, and materials science. Their investment strategy is driven by a commitment to integrating cutting-edge technologies, including next-generation sequencing, artificial intelligence, and hyper-scale computing, to model and manipulate biological systems. KdT Ventures seeks to partner with visionary founders who are dedicated to leveraging these technologies to create innovative solutions that address pressing global challenges. The firm typically invests at the pre-seed, seed, and Series A stages, providing not only capital but also strategic guidance and support to help portfolio companies scale effectively. KdT Ventures is particularly interested in companies that are pioneering advancements in healthcare, agriculture, and materials science, and they look for teams that demonstrate a strong scientific foundation and a clear path to commercialization.
KdT Ventures has built a diverse portfolio of nine innovative companies that exemplify its commitment to advancing frontier science and technology. Notable investments include **PathAI**, which enhances diagnostic accuracy through data-driven pathology analysis, and **Tavros Therapeutics**, an integrated genomics platform focused on discovering next-generation cancer therapies. Another significant portfolio company is **Remedy Robotics**, which develops autonomous navigation software for vascular surgical robots, improving access to critical surgical interventions. Additionally, **Elegen** offers novel gene synthesis technology to accelerate biological engineering, while **Checkerspot** innovates in material science through the genetic engineering of algae. Other key portfolio companies include **STRM.BIO**, which leverages extracellular vesicles for advancements in gene therapies, **Solugen**, which creates environmentally-friendly chemistries as alternatives to traditional petrochemicals, **Dyno Therapeutics**, focused on targeted gene therapy delivery, and **Debut Biotechnology**, which manufactures high-value molecules using custom-designed enzymes. This diverse portfolio reflects KdT Ventures' strategic focus on companies that are not only technologically advanced but also poised to make a significant impact in their respective fields.
To pitch KdT Ventures, founders should visit their contact page at kdtvc.com/contact. They welcome pitches that clearly outline the business model, market potential, and the innovative technology being developed. It is recommended to provide a comprehensive overview of how the startup addresses significant challenges in the relevant sectors.
KdT Ventures invests in early-stage companies, specifically at the pre-seed, seed, and Series A stages. This allows them to support startups from their inception through initial growth phases.
Founders interested in pitching KdT Ventures can do so through their contact page at kdtvc.com/contact. It is advisable to provide a clear overview of your business model, market potential, and how your technology addresses significant challenges.
KdT Ventures primarily focuses on frontier science, biotechnology, healthcare, and materials science. They are particularly interested in companies that are commercializing scientific advancements at the molecular level.
While specific check sizes are not disclosed, KdT Ventures invests in early-stage companies, which typically involves smaller investments compared to later-stage funding rounds. Founders should prepare for discussions regarding their funding needs.
KdT Ventures primarily invests in companies based in the United States. They focus on startups that are innovating within the U.S. market, particularly in the fields of biotechnology and frontier science.
The application process involves submitting a pitch through their contact page. Founders should ensure their submissions are well-prepared, highlighting their innovative solutions and market strategies.
KdT Ventures offers strategic guidance and support to its portfolio companies, helping them navigate the challenges of scaling their businesses. This includes mentorship and access to a network of industry experts.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.